Souhaitez-vous accéder aux communiqués récents ?

Approval Based on Clinical Data from the PREMIER Trial - New Indication Provides Options for Patients with Small or Medium, Wide-Necked Brain Aneurysms DUBLIN - February 7, 2019 - Medtronic plc...

New RESCUE Trial Data Presented in Blunt Thoracic Aortic Injury DUBLIN and SAN DIEGO - January 30, 2019 - Medtronic plc (NYSE:MDT) today announced new data supporting the long-term durability,...

Company Is Committed to Leading Evidence Generation Across the Lung Cancer Care Continuum Medtronic Initiates Separate Study to Evaluate the Safety and Performance of the Emprint(TM) Ablation...

First U.S. Patients Treated Using Mazor X Stealth(TM) Edition at Norton Healthcare and Reston Hospital Center DUBLIN - January 28, 2019 - Medtronic plc (NYSE:MDT) today announced the first U.S....

DiamondTemp Ablation System Represents Disruptive RF Innovation DUBLIN - January 24, 2019 - Medtronic plc (NYSE: MDT) today announced that it has entered into a definitive agreement to acquire...

Data Presented Today at LINC Reiterate Commitment to Patient Safety and Data Transparency DUBLIN and LEIPZIG, Germany - January 22, 2019 - Medtronic plc (NYSE:MDT) today announced new data shared...

Study Will Further Advance Understanding of Effectiveness and Tolerability of the SynchroMed(TM) II Intrathecal Drug Delivery System in Patients Who Have Weaned off Oral Opioids DUBLIN - January...

MyCareLink Heart(TM) Mobile App Allows Pacemaker Patients to Easily Stay Connected with Their Clinics DUBLIN - January 15, 2019 - Medtronic plc (NYSE:MDT) today announced the launch of its...

Program Celebrates the Legacy of Medtronic Co-Founder Earl Bakken and Other Outstanding Patient Advocates Around the World MINNEAPOLIS and Kona, Hawaii - January 9, 2019 - The Medtronic...

  IQcast Feature Aims to Predict the Likelihood of a Low Glucose Event Up to Four Hours in Advance DUBLIN and CAMBRIDGE, Mass. - January 3, 2019 - Medtronic plc (NYSE:MDT), the global leader in...